Searchable abstracts of presentations at key conferences in endocrinology

ea0051dp3.1 | Diabetes professional day: Session 3 | BSPED2017

Type 1 Kidz – Does peer support & education really help?

Brown Chloe

Introduction: Type 1 Kidz is a project, facilitated by Investing in Children CiC, which offers regular group sessions to children and young people living with Type 1 Diabetes and their families across North East England. The aim is to support children and young people to share experiences and stories and learn together to improve their short and long term outcomes. This is supported by a Professional Steering Group.Methods: Monthly or quarterly group ses...

ea0044s4.3 | Advances in the genetic understanding of endocrine disease | SFEBES2016

Somatic mutations and adrenal remodelling in hyperaldosteronism

Brown Morris

Primary Aldosteronism (PA), due to a unilateral aldosterone-producing adenoma of the adrenal (APA), is the commonest curable cause of Hypertension, but the prospects for cure fall with age. APAs rarely increase in size, suggesting an origin much earlier than the development of resistant hypertension. Most APAs have gain-of-function somatic mutations which result in increased Ca2+ entry, and constitutive activation of aldosterone production. Women with larger APAs, a...

ea0059s5.2 | Breast cancer | SFEBES2018

Metabolic pathways regulating breast cancer in obesity

Brown Kristy

Obesity is associated with an increased risk of hormone receptor positive breast cancer after menopause. The aromatase enzyme catalyzes the conversion of androgens into oestrogens and the breast adipose-specific expression of aromatase is hypothesized to be a major driver of breast cancer growth when ovarian oestrogen biosynthesis has ceased. We have found that aromatase is elevated in breast adipose stromal cells in relation to obesity and menopausal status. Furthermore, obes...

ea0038s2.1 | Zoning in on adrenal tumours | SFEBES2015

Somatic mutations and adrenal remodelling in hyperaldosteronism

Brown Morris

Primary Aldosteronism (PA), due to a unilateral aldosterone-producing adenoma of the adrenal (APA), is the commonest curable cause of Hypertension, but the prospects for cure fall with age. APAs rarely increase in size, suggesting an origin much earlier than the development of resistant hypertension. Most APAs have gain-of-function somatic mutations which result in increased Ca2+ entry, and constitutive activation of aldosterone production. Women with larger APAs, a...

ea0038s11.3 | Epigenetics in endocrine-related cancers (Supported by <emphasis role="italic">Endocrine-Related Cancer</emphasis>) | SFEBES2015

Epigenetic signalling and acquired drug resistance in ovarian cancer

Brown Robert

Epigenetic events, such as gene promoter DNA hypermethylation linked to changes in gene expression, are causative of resistance to cytotoxic chemotherapy drugs such as cisplatin in ovarian cancer cell line models, and associated with response to chemotherapy and survival of high grade serous ovarian cancer patients. We are studying the role of epigenetic change throughout the patient journey and how this associates with gene expression changes which can be selected for during ...

ea0061ou6 | Symposium: The role of weight loss in managing type II diabetes | OU2019

Intensive dietary lifestyle interventions in type 2 diabetes

Brown Adrian

Dietary and physical activity lifestyle change remain key components in the management of type 2 diabetes. With dietary factors being of paramount importance. Despite this there remains controversy and confusion on which dietary method or pattern is the most effective in the management of a person’s glycaemia and weight, meaning that patients and clinicians struggle on which way to turn. This session will briefly examine the current dietary guidelines for type 2 diabetes....

ea0094s3.1 | Emerging perspectives on reproductive hormones in breast and prostate cancer | SFEBES2023

Managing impacts of androgen deprivation therapy on bones

Brown Janet

Prostate cancer is projected to be the commonest cancer by 2030, with 1 in 8 men receiving a diagnosis in their lifetime. Although there are more than 400,000 cases in Europe diagnosed each year, many new prostate cancer treatments have been introduced and patients now live with their disease for many years. Consideration of the long-term consequences of treatment is of therefore of increasing importance. More than one third of patients with prostate cancer receive androgen de...

ea0025pl1 | Society for Endocrinology Dale Medal Lecture | SFEBES2011

Fat, sex hormones and breast cancer

Simpson Evan , Brown Kristy

After the menopausal transition, the ovaries cease to make oestrogens, yet the incidence of breast cancer increases with aging and the majority of these tumours are ER positive. So, where is the oestrogen driving this tumour development coming from? Several extra-gonadal sites synthesize oestrogens from circulating C19 steroids, such as bone, brain, and adipose. The largest of these depots is the adipose tissue, and increased BMI is associated with increased breast cancer risk...

ea0002oc3 | Signalling from Cell Surface to Nucleus | SFE2001

Hesx1 represses alpha and LH beta subunit gene expression in vitro and antagonises Pitx1 transactivation, but not synergy between Pitx1 and SF-1 on LH beta subunit

Quirk J , Brown P

The gonadotrophin hormones comprise a common alpha subunit and a hormone specific beta subunit and their expression profiles differ during pituitary ontogeny. The transcriptional regulatory cascade that is required to mediate this is largely unknown. However, perturbation of the expression of homeodomain transcription factors, Paired-like homeodomain transcription factor 1 (Pitx1) and Homeobox gene expressed in embryonic stem cells 1 (Hesx1) disparately affects gonadotrophin g...

ea0007p164 | Neuroendocrinology and behaviour | BES2004

Down-regulation of neurotrophin receptor expression limits the regenerative potential of injured CNS neurons

Brown E , Berry M , Logan A

The application of exogenous neurotrophins (NT) has been widely proposed as a therapeutic strategy for the recovery of regeneration in axotomised CNS neurons. Results from this approach have, however, been disappointing since limited regenerative responses are elicited, we suggest due to limited neurotrophin receptor (NTR) expression. NT exert their trophic effects by signalling through the Trk/p75 receptors. Adequate receptor expression levels must, therefore, be central to t...